TM Editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.

Image Source: Pixabay

The healthcare sector has more high return-generating companies than many other sectors. Even a small drug research company’s share price could shoot up significantly in a day or two if it comes up with a breakthrough research or drug. Thus, healthcare stocks could prove a good investment option for investors with a smaller amount of money to invest.

However, as with any other sector, not all healthcare penny stocks encounter success. In fact, most don’t do that well. Yet those that do win often earn massive returns for investors. Let’s take a look at the 10 best performing penny stocks in the healthcare sector.

10 Best Performing Penny Stocks in the Healthcare Sector

We have used the price and return data to come up with the 10 best performing penny stocks in the healthcare sector. We have ranked these stocks based on their year-to-date return to develop this list. Here are the 10 best performing penny stocks in the healthcare sector.

10. Asensus Surgical, Inc. (ASXC) (80%)

Founded in 1988, Asensus Surgical, Inc. is a medical device company that digitizes the interface between the surgeon and the patient. Its shares are down by almost 17% in the last month, bringing its one-year return to almost 2%.

As of this writing, Asensus Surgical shares were recently seen trading at around $0.65 with a 52-week range of $0.28 to $1.18, giving the company a market capitalization of more than $157 million.

9. Milestone Scientific Inc. (MLSS) (90%)

Founded in 1989, Milestone Scientific Inc. patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. Its shares are up by almost 14% in the last month, bringing its one-year return to almost -37%.

Milestone Scientific shares were recently seen trading at $0.90 with a 52-week range of $0.41 to $1.60, giving the company a market capitalization of more than $62 million.

8. Spectrum Pharmaceuticals, Inc. (SPPI) (94%)

Founded in 1987, Spectrum Pharmaceuticals, Inc. acquires, develops, and commercializes a pipeline of novel and targeted oncology therapies. Its shares are down by over 26% in the last month, bringing its one-year return to almost -44%.

Spectrum Pharmaceuticals shares were recently seen trading at $0.75 with a 52-week range of $0.315 to $1.57, giving the company a market capitalization of more than $152 million.

7. Magenta Therapeutics, Inc. (MGTA) (95%)

Founded in 2015, Magenta Therapeutics, Inc. develops novel medicines for bone marrow transplants. Its shares are down by almost 5% in the last month, bringing its one-year return to around -74%.

Magenta Therapeutics shares were recently seen trading at around $0.79 with a 52-week range of $0.321 to $3.19, giving the company a market capitalization of more than $48 million.

6. Bright Green Corporation (BGXX) (98%)

Founded in 2019, Bright Green Corporation deals in the cultivation, manufacturing, and sale of medical cannabis. Its shares are up by almost 1% in the last month.

Bright Green shares were recently seen trading at above $0.94 with a 52-week range of $0.35 to $58.00, giving the company a market capitalization of more than $159 million.

5. Chembio Diagnostics, Inc. (CEMI) (101%)

Founded in 1985, Chembio Diagnostics, Inc. develops, makes, markets, and licenses rapid medical tests. Its shares are down by almost 1% in the last month, bringing its one-year return to almost -45%.

Chembio Diagnostics shares were recently seen trading at around $0.44 with a 52-week range of $0.19 to $1.24, giving the company a market capitalization of more than $16 million.

4. Hillstream BioPharma, Inc. (HILS) (118%)

Founded in 2017, Hillstream Biopharma, Inc. is a biotechnology company that develops novel therapeutic candidates. Its shares are down by over 34% in the last month, bringing its one-year return to around -43%.

Hillstream BioPharma shares were recently seen trading at around $0.79 with a 52-week range of $0.303 to $2.65, giving the company a market capitalization of more than $9 million.

3. Healthcare Triangle, Inc. (HCTI) (123%)

Founded in 2019, Healthcare Triangle, Inc. is a healthcare information technology company. Its shares are up by over 12% in the last month, bringing its one-year return to almost -68%.

Healthcare Triangle shares were recently seen trading at around $0.40 with a 52-week range of $0.111 to $1.6799, giving the company a market capitalization of more than $16.7 million.

2. Hepion Pharmaceuticals, Inc. (HEPA) (147%)

Founded in 2013, Hepion Pharmaceuticals, Inc. develops therapy for the treatment of chronic liver diseases. Its shares are down by almost 15% in the last month, bringing its one-year return to almost -39%.

Hepion Pharmaceuticals shares were recently seen trading at around $0.77 with a 52-week range of $0.26 to $1.30, giving the company a market capitalization of more than $59 million.

1. Sigilon Therapeutics, Inc. (SGTX) (166%)

Founded in 2015, Sigilon Therapeutics, Inc. deals in the research and development of therapeutic treatments for chronic diseases. Its shares are down by almost 26% in the last month, bringing its one-year return to around -37%.

Sigilon Therapeutics shares were recently seen trading at around $0.93 with a 52-week range of $0.29 to $1.75, giving the company a market capitalization of more than $30 million.

More By This Author: